Type 2 Diabetes Clinical Trials
Advances in blood glucose management, weight loss, and heart health are at the forefront of type 2 diabetes research. Here are some exciting new clinical trials you can join now.
Managing diabetes can be challenging, but researchers and volunteers around the world are working hard to achieve a brighter future for people with type 2 diabetes.
Clinical trials allow researchers to evaluate the safety and efficacy of new drugs and technologies. These trials would not be possible without the thousands of brave volunteers who participate each year.
Here are several trials specifically recruiting people with type 2 diabetes:
Join a study investigating a new oral medication, BMF-219, that could stimulate beta cell growth in people with type 2 diabetes. A study in type 1 diabetes is on the horizon, following FDA clearance earlier this month.
Clinical trials are recruiting participants to see how well the investigational drug CagriSema – a combination of cagrilintide and semaglutide – can reduce blood glucose, body weight, and heart disease.
Five clinical trials are recruiting participants to see how well the investigational drug orforglipron can improve blood glucose levels and reduce body weight.
More clinical trials to watch out for:
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY): This study is investigating how well Mounjaro (tirzepatide) lowers A1C compared to existing treatment options when treatment is started early in adults recently diagnosed with type 2 diabetes.
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE): This trial will examine how well the combination of semaglutide and a low dose of insulin glargine helps lower blood sugar compared to a higher dose of insulin glargine in people with type 2 diabetes.
Surgical or Medical Treatment (ST2OMP): Researchers are testing the hypothesis that bariatric surgery will lead to better long-term glycemic control and better reduce complications compared to intensive medications in children and teens with type 2 diabetes aged 13-20 years.
Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification (GEM): This study will compare the use of continuous glucose monitors (CGM) with a structured lifestyle program (called GEM) to usual care in adults who were recently diagnosed with type 2 diabetes within the past 12 months.
Learn more about type 2 diabetes research and treatments here: